Publication | Open Access
Cerebrospinal fluid neurogranin/β‐site APP‐cleaving enzyme 1 predicts cognitive decline in preclinical Alzheimer's disease
26
Citations
34
References
2018
Year
High Ng/BACE1 ratio predicts cognitive decline also in preclinical cases with amyloid plaques.
| Year | Citations | |
|---|---|---|
Page 1
Page 1